Artificial intelligence is accelerating demand for increasingly powerful microchips - ZEISS SMT is strategically expanding its capacity to meet this demand Expansion in Oberkochen creates around 25,000 square meters of additional space for production and production-related areas; move-in to first office spaces marks an important milestone Investments in Germany and internationally strengthen ZEISS SMT’s presence [...]

WALTHAM, Mass. -- Nova Biomedical today announced a transaction involving certain assets of NanoCellect, a provider of microfluidic cell sorting technology. This expands Nova Biomedical's capabilities in cell line development and strengthens its ability to support biopharmaceutical workflows from early development through manufacturing. NanoCellect® WOLF G2® cell sorting platform introduces gentle, microfluidic-based cell selection and isolation, complementing [...]

“Opening our Milton Park facility is an important step in strengthening how we support researchers across the UK and Europe.” Melbourne, Australia / Milton, United Kingdom -- IonOpticks today announces a significant expansion of its UK and European presence, with the official opening of a purpose-built facility in Oxfordshire UK, extending the company’s global infrastructure alongside [...]

Countable Certified Service Providers are certified by Countable Labs for demonstrated expertise using Countable PCR technology to support studies of all sizes PALO ALTO, Calif. -- Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, today announced its Countable Certified Service Provider (CSP) program. The Countable CSP [...]

Pythia Biosciences and Lexogen recently announced a strategic partnership to empower researchers with deeper biological insights by combining Lexogen’s expertise in RNA sequencing and library preparation with Pythia’s multi-omics data curation and analytics capabilities. Through this collaboration, Pythia will offer Lexogen’s wet-lab capabilities via direct sales and as a core component of its newly launched expanded data ecosystem [...]

One delay column solution helps laboratories simplify workflows, reduce system interference and future-proof PFAS methods for emerging compounds TORRANCE, CA, - Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences, today announced the launch of the PFAS Universal Delay Column, a new addition to its Designed [...]

Qmicro by Sensirion announces the launch of the DynamiQ-X universal, a new addition to the DynamiQ-X series and a breakthrough in globally deployable micro-gas chromatograph technology. Engineered for organizations operating in demanding industrial and hazardous environments, the DynamiQ-X universal delivers true international readiness without compromise. Certified to ATEX, IECEx and cQPSus, the DynamiQ-X universal meets [...]

Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics Showcasing Roche's portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901 INDIANAPOLIS -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing [...]

immunoMUSE® enables flexible, high-sensitivity multiplex immunofluorescence with user-defined antibodies. Schlieren, Switzerland – arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced a distribution partnership with Europa Biosite, a leading distributor of life science research products and services. Through this partnership, Europa Biosite will distribute arcoris bio’s newly launched immunoMUSE® kits in [...]

Technology License Partnership provides Genentech access to MaxCyte’s portfolio of platform technologies across research, development, and manufacturing workflows ROCKVILLE, Md. -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics, today announced that it has entered into a technology license partnership [...]